These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Dick P; Wallner H; Sabeti S; Loewe C; Mlekusch W; Lammer J; Koppensteiner R; Minar E; Schillinger M Catheter Cardiovasc Interv; 2009 Dec; 74(7):1090-5. PubMed ID: 19859954 [TBL] [Abstract][Full Text] [Related]
6. Timing of the restenosis following nitinol stenting in the superficial femoral artery and the factors associated with early and late restenoses. Iida O; Uematsu M; Soga Y; Hirano K; Suzuki K; Yokoi H; Muramatsu T; Inoue N; Nanto S; Nagata S Catheter Cardiovasc Interv; 2011 Oct; 78(4):611-7. PubMed ID: 21805562 [TBL] [Abstract][Full Text] [Related]
8. A network meta-analysis of randomized controlled trials comparing treatment modalities for de novo superficial femoral artery occlusive lesions. Antonopoulos CN; Mylonas SN; Moulakakis KG; Sergentanis TN; Sfyroeras GS; Lazaris AM; Kakisis JD; Vasdekis SN J Vasc Surg; 2017 Jan; 65(1):234-245.e11. PubMed ID: 27865639 [TBL] [Abstract][Full Text] [Related]
9. How should we manage thrombosis of Viabahn stent-graft? A case report focused on catheter-directed thrombolysis. Kang WY; Campia U; Bernardo NL; Didier RJ; Negi SI; Kiramijyan S; Koifman E; Baker NC; Lipinski MJ; Escarcega RO; Torguson R; Waksman R Cardiovasc Revasc Med; 2016 Mar; 17(2):134-7. PubMed ID: 26994746 [TBL] [Abstract][Full Text] [Related]
10. Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: a propensity-matched analysis. Kawamura Y; Ishii H; Aoyama T; Tanaka M; Takahashi H; Kumada Y; Toriyama T; Murohara T J Vasc Surg; 2009 Nov; 50(5):1057-62. PubMed ID: 19782527 [TBL] [Abstract][Full Text] [Related]
11. Hybrid surgical and endovascular therapy in multifocal peripheral TASC D lesions: up to three-year follow-up. Nishibe T; Kondo Y; Dardik A; Muto A; Koizumi J; Nishibe M J Cardiovasc Surg (Torino); 2009 Aug; 50(4):493-9. PubMed ID: 19734834 [TBL] [Abstract][Full Text] [Related]
12. Selective stenting in subintimal angioplasty: analysis of primary stent outcomes. Schmieder GC; Richardson AI; Scott EC; Stokes GK; Meier GH; Panneton JM J Vasc Surg; 2008 Nov; 48(5):1175-80; discussion 1180-1. PubMed ID: 18778911 [TBL] [Abstract][Full Text] [Related]
13. Impact of chronic kidney disease on outcomes of superficial femoral artery endoluminal interventions. Bakken AM; Protack CD; Saad WE; Hart JP; Rhodes JM; Waldman DL; Davies MG Ann Vasc Surg; 2009; 23(5):560-8. PubMed ID: 19128934 [TBL] [Abstract][Full Text] [Related]
14. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease. Geraghty PJ; Mewissen MW; Jaff MR; Ansel GM; J Vasc Surg; 2013 Aug; 58(2):386-95.e4. PubMed ID: 23676191 [TBL] [Abstract][Full Text] [Related]
15. Clinical follow-up in endovascular treatment for TASC C-D lesions in femoro-popliteal segment. Rabellino M; Zander T; Baldi S; Garcia Nielsen L; Aragon-Sanchez FJ; Zerolo I; Llorens R; Maynar M Catheter Cardiovasc Interv; 2009 Apr; 73(5):701-5. PubMed ID: 19309709 [TBL] [Abstract][Full Text] [Related]
16. Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery. Soga Y; Iida O; Hirano K; Suzuki K; Tosaka A; Yokoi H; Nobuyoshi M J Vasc Surg; 2011 Oct; 54(4):1058-66. PubMed ID: 21880459 [TBL] [Abstract][Full Text] [Related]
17. MISAGO 2: one-year outcomes after implantation of the Misago self-expanding nitinol stent in the superficial femoral and popliteal arteries of 744 patients. Schulte KL; Kralj I; Gissler HM; Bagnaschino LA; Buschmann I; Pernès JM; Haage P; Goverde P; Beregi JP; Válka M; Boudny J; Geibel T; Velkoborsky M; Zähringer M; Paetzel C; Fanelli F; Müller-Hülsbeck S; Zeller T; Langhoff R J Endovasc Ther; 2012 Dec; 19(6):774-84. PubMed ID: 23210876 [TBL] [Abstract][Full Text] [Related]
18. Mid-term outcome after endovascular therapy in the superficial femoral and popliteal artery using long stents. Schoenefeld E; Donas KP; Schönefeld T; Osada N; Austermann M; Torsello G Vasa; 2012 Jan; 41(1):49-56. PubMed ID: 22247060 [TBL] [Abstract][Full Text] [Related]
19. The role of superficial femoral artery endoluminal bypass in long de novo lesions and in-stent restenosis. Doomernik DE; Golchehr B; Lensvelt MM; Reijnen MM J Cardiovasc Surg (Torino); 2012 Aug; 53(4):447-57. PubMed ID: 22854524 [TBL] [Abstract][Full Text] [Related]
20. Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases. Ascher E; Marks NA; Hingorani AP; Schutzer RW; Mutyala M J Vasc Surg; 2006 Dec; 44(6):1230-7; discussion 1237-8. PubMed ID: 17055689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]